Market Research Logo

China Procalcitonin Antibody Market Research Report 2017

China Procalcitonin Antibody Market Research Report 2017

In the recent years, procalcitonin antibody industry developed rapidly in China, The China procalcitonin antibody market had reached 34.7 g in 2016 and is expected to increase reach 52.9 g by 2023. In terms of revenue, the China procalcitonin antibody market was valued 5.68 Million USD in 2016, and is estimated to be worth 10.61 Million USD by 2023.

This report studies the Procalcitonin Antibody development status and future trend in China, focuses on top players in China, also splits Procalcitonin Antibody by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include
Thermo Fisher
Roche Diagnostics
bioMerieux
HyTest
Wondfo
Ningbo Medicalsystem Biotechnology
Snibe
Vazyme Biotech
Getein Biotech
Hotgen Biotech
Lumigenex
Shanghai Medicine'nest Pharmaceutical
Kitgen
Beijing KeyGen
Fantibody

Geographically, this report splits the China market into six regions,
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China

On the basis of product, the Procalcitonin Antibody market is primarily split into
Polyclonal Procalcitonin Antibody
Monoclonal Procalcitonin Antibody

On the basis on the end users/applications, this report covers
Hospital
Medical research institutions
Others


1 Procalcitonin Antibody Overview
1.1 Product Overview and Scope of Procalcitonin Antibody
1.2 Classification of Procalcitonin Antibody by Product Category
1.2.1 China Procalcitonin Antibody Sales (mg) Comparison by Types (2012-2017)
1.2.2 China Procalcitonin Antibody Sales (mg) Market Share by Types in 2016
1.2.3 Polyclonal Procalcitonin Antibody
1.2.4 Monoclonal Procalcitonin Antibody
1.3 China Procalcitonin Antibody Market by Applications/End Users
1.3.1 China Procalcitonin Antibody Sales (mg) and Market Share Comparison by Applications (2012-2022)
1.3.2 Hospital
1.3.3 Medical Research Institutions
1.4 China Procalcitonin Antibody Market by Regions
1.4.1 China Procalcitonin Antibody Market Size (K USD) Comparison by Regions (2012-2023)
1.4.2 South China Procalcitonin Antibody Status and Prospect (2012-2023)
1.4.3 East China Procalcitonin Antibody Status and Prospect (2012-2023)
1.4.4 Southwest China Procalcitonin Antibody Status and Prospect (2012-2023)
1.4.5 Northeast China Procalcitonin Antibody Status and Prospect (2012-2023)
1.4.6 North China Procalcitonin Antibody Status and Prospect (2012-2023)
1.4.7 Central China Procalcitonin Antibody Status and Prospect (2012-2023)
1.5 China Market Size (Sales and Revenue) of Procalcitonin Antibody (2012-2023)
1.5.1 China Procalcitonin Antibody Sales (mg) and Growth Rate (%) (2012-2023)
1.5.2 China Procalcitonin Antibody Revenue (K USD) and Growth Rate (2012-2023)
2 China Procalcitonin Antibody Market Competition by Players/Manufacturers
2.1 China Procalcitonin Antibody Sales and Market Share of Key Players/Manufacturers (2012-2017)
2.2 China Procalcitonin Antibody Revenue and Share by Players/Manufacturers (2012-2017)
2.3 China Procalcitonin Antibody Average Price (USD/mg) by Players/Manufacturers (2012-2017)
2.4 China Procalcitonin Antibody Market Competitive Situation and Trends
2.4.1 China Procalcitonin Antibody Market Concentration Rate
2.4.2 China Procalcitonin Antibody Market Share of Top 3 and Top 5 Players/Manufacturers
2.5 China Players/Manufacturers Procalcitonin Antibody Manufacturing Base Distribution, Sales Area, Product Types
3 China Antibody Sales and Revenue by Regions (2012-2017)
3.1 China Antibody Sales (mg) and Market Share by Regions (2012-2017)
3.2 China Antibody Revenue (K USD) and Market Share by Regions (2012-2017)
3.3 China Antibody Price (USD/mg) by Regions (2012-2017)
4 China Antibody Sales and Revenue by Type/ Product Category (2012-2017)
4.1 China Antibody Sales (mg) and Market Share by Type/ Product Category (2012-2017)
4.2 China Antibody Revenue (K USD) and Market Share by Type (2012-2017)
4.3 China Antibody Price (USD/mg) by Type (2012-2017)
4.4 China Antibody Sales Growth Rate (%) (%) by Type (2012-2017)
5 China Procalcitonin Antibody Sales by Application (2012-2017)
5.1 China Procalcitonin Antibody Sales (mg) and Market Share by Applications (2012-2017)
5.2 China Procalcitonin Antibody Sales Growth Rate (%) (%) by Applications (2012-2017)
5.3 Market Drivers and Opportunities
6 China Procalcitonin Antibody Players/Manufacturers Profiles and Sales Data
6.1 Thermo Fisher Scientific
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Procalcitonin Antibody Product Description
6.1.3 Thermo Fisher Scientific Procalcitonin Antibody Sales (mg), Revenue (K USD), Price (USD/mg) and Gross Margin (%) (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Roche Diagnostics
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Procalcitonin Antibody Product Description
6.2.3 Roche Diagnostics Procalcitonin Antibody Sales (mg), Revenue (K USD), Price (USD/mg) and Gross Margin (%) (2012-2017)
6.2.4 Main Business/Business Overview
6.3 BioMerieux
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Procalcitonin Antibody Product Description
6.3.3 BioMerieux Procalcitonin Antibody Sales (mg), Revenue (K USD), Price (USD/mg) and Gross Margin (%) (2012-2017)
6.3.4 Main Business/Business Overview
6.4 HyTest
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Procalcitonin Antibody Product Description
6.4.3 HyTest Procalcitonin Antibody Sales (mg), Revenue (K USD), Price (USD/mg) and Gross Margin (%) (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Wondfo
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Procalcitonin Antibody Product Description
6.5.3 Wondfo Procalcitonin Antibody Sales (mg), Revenue (K USD), Price (USD/mg) and Gross Margin (%) (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Ningbo Medicalsystem Biotechnology
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Procalcitonin Antibody Product Description
6.6.3 Ningbo Medicalsystem Biotechnology Procalcitonin Antibody Sales (mg), Revenue (K USD), Price (USD/mg) and Gross Margin (%) (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Snibe
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Procalcitonin Antibody Product Description
6.7.3 Snibe Procalcitonin Antibody Sales (mg), Revenue (K USD), Price (USD/mg) and Gross Margin (%) (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Vazyme Biotech
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Procalcitonin Antibody Product Description
6.8.3 Vazyme Biotech Procalcitonin Antibody Sales (mg), Revenue (K USD), Price (USD/mg) and Gross Margin (%) (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Getein Biotech
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Procalcitonin Antibody Product Description
6.9.3 Getein Biotech Procalcitonin Antibody Sales (mg), Revenue (K USD), Price (USD/mg) and Gross Margin (%) (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Hotgen Biotech
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Procalcitonin Antibody Product Description
6.10.3 Hotgen Biotech Procalcitonin Antibody Sales (mg), Revenue (K USD), Price (USD/mg) and Gross Margin (%) (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Lumigenex
6.11.1 Company Basic Information, Manufacturing Base and Competitors
6.11.2 Procalcitonin Antibody Product Description
6.11.3 Lumigenex Procalcitonin Antibody Sales (mg), Revenue (K USD), Price (USD/mg) and Gross Margin (%) (2012-2017)
6.11.4 Main Business/Business Overview
6.12 Shanghai Medicine¡¯nest Pharmaceutical
6.12.1 Company Basic Information, Manufacturing Base and Competitors
6.12.2 Procalcitonin Antibody Product Description
6.12.3 Shanghai Medicine¡¯nest Pharmaceutical Procalcitonin Antibody Sales (mg), Revenue (K USD), Price (USD/mg) and Gross Margin (%) (2012-2017)
6.12.4 Main Business/Business Overview
6.13 Kitgen
6.13.1 Company Basic Information, Manufacturing Base and Competitors
6.13.2 Procalcitonin Antibody Product Description
6.13.3 Kitgen Procalcitonin Antibody Sales (mg), Revenue (K USD), Price (USD/mg) and Gross Margin (%) (2012-2017)
6.13.4 Main Business/Business Overview
6.14 Beijing KeyGen
6.14.1 Company Basic Information, Manufacturing Base and Competitors
6.14.2 Procalcitonin Antibody Product Description
6.14.3 Beijing KeyGen Procalcitonin Antibody Sales (mg), Revenue (K USD), Price (USD/mg) and Gross Margin (%) (2012-2017)
6.14.4 Main Business/Business Overview
6.15 Fantibody
6.15.1 Company Basic Information, Manufacturing Base and Competitors
6.15.2 Procalcitonin Antibody Product Description
6.15.3 Fantibody Procalcitonin Antibody Sales (mg), Revenue (K USD), Price (USD/mg) and Gross Margin (%) (2012-2017)
6.15.4 Main Business/Business Overview
7 Procalcitonin Antibody Manufacturing Cost Analysis
7.1 Procalcitonin Antibody Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Peptone Market Analysis
7.1.3 Yeast Market Analysis
7.1.4 Sodium Chloride Market Analysis
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Procalcitonin Antibody
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Procalcitonin Antibody Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Procalcitonin Antibody Major Players/Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 China Procalcitonin Antibody Market Size (Sales and Revenue) Forecast (2018F-2023F)
11.1 China Procalcitonin Antibody Sales (mg), Revenue (K USD) Forecast (2018F-2023F)
11.2 China Procalcitonin Antibody Sales (mg) Forecast by Type (2018F-2023F)
11.3 China Procalcitonin Antibody Sales (mg) Forecast by Application (2018F-2023F)
11.4 China Procalcitonin Antibody Sales (mg) Forecast by Regions (2018F-2023F)
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables and Figures
Figure Product Picture of Procalcitonin Antibody
Table China Procalcitonin Antibody Sales (mg) and Growth Rate (%) Comparison by Types (Product Category) (2012-2017)
Figure China Procalcitonin Antibody Sales Volume Market Share by Types in 2016
Figure Polyclonal Procalcitonin Antibody Product Picture
Figure Monoclonal Procalcitonin Antibody Product Picture
Table China Procalcitonin Antibody Sales (mg) Comparison by Applications (2012-2022)
Figure China Sales Market Share (%) of Procalcitonin Antibody by Applications in 2016
Figure Hospital Application Examples
Figure Medical research institutions Examples
Table China Procalcitonin Antibody Sales (mg) Comparison by Regions (2012-2022)
Figure South China Procalcitonin Antibody Revenue (K USD) and Growth Rate (2012-2017)
Figure South China Procalcitonin Antibody Revenue (K USD) and Growth Rate (2018-2023)
Figure East China Procalcitonin Antibody Revenue (K USD) and Growth Rate (2012-2017)
Figure East China Procalcitonin Antibody Revenue (K USD) and Growth Rate (2018-2023)
Figure Southwest China Procalcitonin Antibody Revenue (K USD) and Growth Rate (2012-2017)
Figure Southwest China Procalcitonin Antibody Revenue (K USD) and Growth Rate (2018-2023)
Figure Northeast China Procalcitonin Antibody Revenue (K USD) and Growth Rate (2012-2017)
Figure Northeast China Procalcitonin Antibody Revenue (K USD) and Growth Rate (2018-2023)
Figure North China Procalcitonin Antibody Revenue (K USD) and Growth Rate (2012-2017)
Figure North China Procalcitonin Antibody Revenue (K USD) and Growth Rate (2018-2023)
Figure Central China Procalcitonin Antibody Revenue (K USD) and Growth Rate (2012-2017)
Figure Central China Procalcitonin Antibody Revenue (K USD) and Growth Rate (2018-2023)
Figure China Procalcitonin Antibody Sales (mg) and Growth Rate (%) (2012-2023)
Figure China Procalcitonin Antibody Revenue (K USD) and Growth Rate (2012-2023)
Table China Procalcitonin Antibody Sales (mg) of Key Players/Manufacturers (2012-2017)
Table China Procalcitonin Antibody Sales Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Procalcitonin Antibody Sales Share (%) by Players/Manufacturers
Figure 2017 China Procalcitonin Antibody Sales Share (%) by Players/Manufacturers
Table China Procalcitonin Antibody Revenue by Players/Manufacturers (2012-2017)
Table China Procalcitonin Antibody Revenue Market Share (%) by Players/Manufacturers (2012-2017)
Figure 2016 China Procalcitonin Antibody Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Procalcitonin Antibody Revenue Market Share (%) by Players/Manufacturers
Table China Market Procalcitonin Antibody Average Price of Key Players/Manufacturers (2012-2017)
Figure China Market Procalcitonin Antibody Average Price of Key Players/Manufacturers in 2016
Figure China Market Procalcitonin Antibody Average Price of Key Players/Manufacturers in 2017
Figure 2016 China Procalcitonin Antibody Market Share of Top 3 Players/Manufacturers
Figure China Procalcitonin Antibody Market Share of Top 3 Players/Manufacturers
Figure China Procalcitonin Antibody Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Procalcitonin Antibody Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Procalcitonin Antibody Product Category
Table China Antibody Sales (mg) by Regions (2012-2017)
Table China Antibody Sales Share (%) by Regions (2012-2017)
Figure China Antibody Sales Share (%) by Regions in 2012
Figure China Antibody Sales Market Share (%) by Regions in 2016
Table China Antibody Revenue (K USD) and Market Share by Regions (2012-2017)
Table China Antibody Revenue Market Share (%) by Regions (2012-2017)
Figure China Antibody Revenue Market Share (%) by Regions (2012-2017)
Figure China Antibody Revenue Market Share (%) by Regions in 2016
Table China Antibody Price (USD/mg) by Regions (2012-2017)
Table China Antibody Sales (mg) by Type (2012-2017)
Table China Antibody Sales Share (%) by Type (2012-2017)
Figure China Antibody Sales Share (%) by Type 2012
Figure China Antibody Sales Market Share (%) by Type in 2016
Table China Antibody Revenue (K USD) and Market Share by Type (2012-2017)
Table China Antibody Revenue Market Share (%) by Type (2012-2017)
Figure Revenue Market Share of Antibody by Type in 2012
Figure Revenue Market Share of Antibody by Type in 2016
Table China Antibody Price (USD/mg) by Types (2012-2017)
Figure China Antibody Sales Growth Rate (%) (%) by Type (2012-2017)
Table China Procalcitonin Antibody Sales (mg) by Applications (2012-2017)
Table China Procalcitonin Antibody Sales Market Share (%) by Applications (2012-2017)
Figure China Procalcitonin Antibody Sales Market Share (%) by Applications (2012-2017)
Figure China Procalcitonin Antibody Sales Market Share (%) by Applications in 2016
Table China Procalcitonin Antibody Sales Growth Rate (%) (%) by Applications (2012-2017)
Figure China Procalcitonin Antibody Sales Growth Rate (%) by Applications (2012-2017)
Table Thermo Fisher Scientific Basic Information List
Table Procalcitonin Antibody Product Description
Table Thermo Fisher Scientific Procalcitonin Antibody Sales (mg), Revenue (K USD), Price (USD/mg) and Gross Margin (%) (2012-2017)
Figure Thermo Fisher Scientific Procalcitonin Antibody Sales Growth Rate (%) (2012-2017)
Figure Thermo Fisher Scientific Procalcitonin Antibody Sales Market Share (%) in China (2012-2017)
Figure Thermo Fisher Scientific Procalcitonin Antibody Revenue Market Share (%) in China (2012-2017)
Table Roche Diagnostics Basic Information List
Figure Procalcitonin Antibody Product Picture
Table Roche Diagnostics Procalcitonin Antibody Sales (mg), Revenue (K USD), Price (USD/mg) and Gross Margin (%) (2012-2017)
Figure Roche Diagnostics Procalcitonin Antibody Sales Growth Rate (%) (2012-2017)
Figure Roche Diagnostics Procalcitonin Antibody Sales Market Share (%) in China (2012-2017)
Figure Roche Diagnostics Procalcitonin Antibody Revenue Market Share (%) in China (2012-2017)
Table BioMerieux Basic Information List
Table Technical specifications for VIDAS B.R.A.H.M.S. PCT of BioMerieux
Table BioMerieux Procalcitonin Antibody Sales (mg), Revenue (K USD), Price (USD/mg) and Gross Margin (%) (2012-2017)
Figure BioMerieux Procalcitonin Antibody Sales Growth Rate (%) (2012-2017)
Figure BioMerieux Procalcitonin Antibody Sales Market Share (%) in China (2012-2017)
Figure BioMerieux Procalcitonin Antibody Revenue Market Share (%) in China (2012-2017)
Table HyTest Basic Information List
Table Procalcitonin Antibody Picture and Specifications of HyTest
Table HyTest Procalcitonin Antibody Sales (mg), Revenue (K USD), Price (USD/mg) and Gross Margin (%) (2012-2017)
Figure HyTest Procalcitonin Antibody Sales Growth Rate (%) (2012-2017)
Figure HyTest Procalcitonin Antibody Sales Market Share (%) in China (2012-2017)
Figure HyTest Procalcitonin Antibody Revenue Market Share (%) in China (2012-2017)
Table Wondfo Basic Information List
Figure Procalcitonin Antibody Product Picture
Table Wondfo Procalcitonin Antibody Sales (mg), Revenue (K USD), Price (USD/mg) and Gross Margin (%) (2012-2017)
Figure Wondfo Procalcitonin Antibody Sales Growth Rate (%) (2012-2017)
Figure Wondfo Procalcitonin Antibody Sales Market Share (%) in China (2012-2017)
Figure Wondfo Procalcitonin Antibody Revenue Market Share (%) in China (2012-2017)
Table Ningbo Medicalsystem Biotechnology Basic Information List
Figure Procalcitonin Picture of Ningbo Medicalsystem Biotechnology
Table Ningbo Medicalsystem Biotechnology Procalcitonin Antibody Sales (mg), Revenue (K USD), Price (USD/mg) and Gross Margin (%) (2012-2017)
Figure Ningbo Medicalsystem Biotechnology Procalcitonin Antibody Sales Growth Rate (%) (2012-2017)
Figure Ningbo Medicalsystem Biotechnology Procalcitonin Antibody Sales Market Share (%) in China (2012-2017)
Figure Ningbo Medicalsystem Biotechnology Procalcitonin Antibody Revenue Market Share (%) in China (2012-2017)
Table Snibe Basic Information List
Figure Procalcitonin Picture of Snibe
Table Snibe Procalcitonin Antibody Sales (mg), Revenue (K USD), Price (USD/mg) and Gross Margin (%) (2012-2017)
Figure Snibe Procalcitonin Antibody Sales Growth Rate (%) (2012-2017)
Figure Snibe Procalcitonin Antibody Sales Market Share (%) in China (2012-2017)
Figure Snibe Procalcitonin Antibody Revenue Market Share (%) in China (2012-2017)
Table Vazyme Biotech Basic Information List
Figure Procalcitonin Picture of Vazyme Biotech
Table Vazyme Biotech Procalcitonin Antibody Sales (mg), Revenue (K USD), Price (USD/mg) and Gross Margin (%) (2012-2017)
Figure Vazyme Biotech Procalcitonin Antibody Sales Growth Rate (%) (2012-2017)
Figure Vazyme Biotech Procalcitonin Antibody Sales Market Share (%) in China (2012-2017)
Figure Vazyme Biotech Procalcitonin Antibody Revenue Market Share (%) in China (2012-2017)
Table Getein Biotech Basic Information List
Figure Procalcitonin Picture of Getein Biotech

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report